In contrast to our findings, cisplatin-resistant H460 cells grown in TSC conditions were enriched in CSCs markers (CD133+) and displayed higher tumorigenic and metastatic potential [62], an effect that could be explained by the co-selection of prometastatic properties induced by chemoresistance. The gene discussed is PROM1; the disease is tuberous sclerosis.